BlackRock Advisors’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-7,566
| Closed | -$4K | – | 3733 |
|
|
2016
Q3 | $4K | Hold |
7,566
| – | – | ﹤0.01% | 3598 |
|
|
2016
Q2 | $4K | Sell |
7,566
-12,280
| -62% | -$6.49K | ﹤0.01% | 3631 |
|
|
2016
Q1 | $29K | Hold |
19,846
| – | – | ﹤0.01% | 3283 |
|
|
2015
Q4 | $64K | Sell |
19,846
-10,575
| -35% | -$34.1K | ﹤0.01% | 3065 |
|
|
2015
Q3 | $190K | Buy |
30,421
+562
| +2% | +$3.51K | ﹤0.01% | 2720 |
|
|
2015
Q2 | $296K | Buy |
29,859
+3,672
| +14% | +$36.4K | ﹤0.01% | 2521 |
|
|
2015
Q1 | $193K | Buy |
26,187
+5,428
| +26% | +$40K | ﹤0.01% | 2669 |
|
|
2014
Q4 | $111K | Buy |
20,759
+613
| +3% | +$3.28K | ﹤0.01% | 2957 |
|
|
2014
Q3 | $101K | Buy |
20,146
+5,157
| +34% | +$25.9K | ﹤0.01% | 2965 |
|
|
2014
Q2 | $101K | Buy |
+14,989
| New | +$101K | ﹤0.01% | 3016 |
|
|
2014
Q1 | – | Sell |
-56,241
| Closed | -$212K | – | 3670 |
|
|
2013
Q4 | $212K | Buy |
+56,241
| New | +$212K | ﹤0.01% | 2606 |
|